Verrica Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	7.57	5.12	9.03	12	-	Upgrade
Revenue Growth (YoY)	47.66%	-43.27%	-24.73%	-	-	Upgrade
Cost of Revenue	14.58	21.04	12.92	15.93	-	Upgrade
Gross Profit	-7.01	-15.92	-3.89	-3.93	-	Upgrade
Selling, General & Admin	58.02	47.31	17.41	26.98	24.51	Upgrade
Research & Development	-	-	-	-	15.67	Upgrade
Operating Expenses	58.02	47.31	17.41	26.98	40.18	Upgrade
Operating Income	-65.04	-63.22	-21.3	-30.91	-40.18	Upgrade
Interest Expense	-9.41	-3.96	-2.17	-4.3	-3.03	Upgrade
Interest & Investment Income	1.42	2.74	0.48	0.12	0.52	Upgrade
Other Non Operating Income (Expenses)	-2.67	-0.01	-0.06	-	-	Upgrade
EBT Excluding Unusual Items	-75.7	-64.46	-23.05	-35.08	-42.69	Upgrade
Gain (Loss) on Sale of Assets	-0.08	-2.54	-	-	-	Upgrade
Legal Settlements	-0.8	-	-	-	-	Upgrade
Other Unusual Items	-	-	-1.44	-	-	Upgrade
Pretax Income	-76.58	-67	-24.49	-35.08	-42.69	Upgrade
Earnings From Continuing Operations	-76.58	-67	-24.49	-35.08	-42.69	Upgrade
Net Income	-76.58	-67	-24.49	-35.08	-42.69	Upgrade
Net Income to Common	-76.58	-67	-24.49	-35.08	-42.69	Upgrade
Shares Outstanding (Basic)	52	45	34	27	25	Upgrade
Shares Outstanding (Diluted)	52	45	34	27	25	Upgrade
Shares Change (YoY)	14.26%	32.72%	26.32%	8.20%	0.39%	Upgrade
EPS (Basic)	-1.48	-1.48	-0.72	-1.30	-1.71	Upgrade
EPS (Diluted)	-1.48	-1.48	-0.72	-1.30	-1.71	Upgrade
Free Cash Flow	-60.95	-38.94	-18.95	-28.47	-31.68	Upgrade
Free Cash Flow Per Share	-1.18	-0.86	-0.56	-1.05	-1.27	Upgrade
Gross Margin	-92.70%	-	-43.08%	-32.74%	-	Upgrade
Operating Margin	-859.58%	-1233.84%	-235.78%	-257.57%	-	Upgrade
Profit Margin	-1012.15%	-1307.47%	-271.11%	-292.33%	-	Upgrade
Free Cash Flow Margin	-805.63%	-759.93%	-209.83%	-237.21%	-	Upgrade
EBITDA	-64.08	-62.67	-20.84	-30.66	-40.14	Upgrade
EBITDA Margin	-	-	-230.76%	-255.53%	-	Upgrade
D&A For EBITDA	0.96	0.55	0.45	0.24	0.04	Upgrade
EBIT	-65.04	-63.22	-21.3	-30.91	-40.18	Upgrade
EBIT Margin	-	-	-235.78%	-257.57%	-	Upgrade
Revenue as Reported	7.57	5.12	9.03	-	-	Upgrade

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q